Motivating Persons with Schizophrenia Spectrum Disorders to Exercise: Rationale and Design
- PMID: 20204148
- PMCID: PMC2831651
- DOI: 10.3371/CSRP.3.2.6
Motivating Persons with Schizophrenia Spectrum Disorders to Exercise: Rationale and Design
Abstract
Persons with schizophrenia spectrum disorders (SSDs) are not only at risk because of disabling disease symptoms but because necessary medications create health risks associated with high rates of obesity. Despite the well-known benefits of exercise, persons with SSDs rarely adhere to such regimens; few interventions to motivate exercise behavior have been tested in this group.The purpose of this study is to examine effects of the Walk, Address sensations, Learn about exercise, Cue exercise behavior for persons with SSDs (WALC-S) motivational intervention upon exercise behavior. We will recruit a total of eighty outpatients 18-68 years, meeting these criteria: 1) chart diagnosis of schizophrenia, any subtype, schizoaffective disorder or schizophreniform disorder, according to the criteria described in the Diagnostic and Statistical Manual for Mental Disorders, 2) English speaking, 3) Stable medication regimen (defined as no medication changes within the last month), and 4) medical clearance for moderate exercise in writing from primary care provider. Participants will be randomly assigned to the experimental (4-week WALC-S motivational intervention), or the control group (4-week time and attention control). After the first 4 weeks, all participants will attend a 16-week walking group.The primary measures of the effectiveness of the WALC-S are attendance, persistence and compliance to the 16-week walking group. The study will be completed in approximately January 2010. In addition to hypothesis testing, this study will provide information to estimate effect sizes to calculate power and determine appropriate sample sizes for future inquiries. This paper describes the rationale and design of the study.
Figures
Similar articles
-
Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disorders.Community Ment Health J. 2011 Dec;47(6):628-36. doi: 10.1007/s10597-010-9363-8. Epub 2010 Nov 27. Community Ment Health J. 2011. PMID: 21113661 Free PMC article. Clinical Trial.
-
Effect of a motivational group intervention on exercise self-efficacy and outcome expectations for exercise in schizophrenia spectrum disorders.J Am Psychiatr Nurses Assoc. 2010 Mar;16(2):105-13. doi: 10.1177/1078390310364428. J Am Psychiatr Nurses Assoc. 2010. PMID: 21659268
-
Effect of a motivational group intervention upon exercise self efficacy and outcome expectations for exercise in Schizophrenia Spectrum Disorders (SSDs).J Am Psychiatr Nurses Assoc. 2010 Apr;16(2):105-13. doi: 10.1177/1078390310364428. J Am Psychiatr Nurses Assoc. 2010. PMID: 20445768 Free PMC article. Clinical Trial.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: An Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Sep. Report No.: 18-05239-EF-1. PMID: 30354042 Free Books & Documents. Review.
Cited by
-
Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia.Biol Res Nurs. 2011 Oct;13(4):383-90. doi: 10.1177/1099800410393272. Epub 2010 Dec 30. Biol Res Nurs. 2011. PMID: 21196420 Free PMC article.
-
Meet me at the crossroads: clinical research engages practitioners, educators, students, and patients.Perspect Psychiatr Care. 2012 Apr;48(2):76-82. doi: 10.1111/j.1744-6163.2011.00306.x. Epub 2011 Apr 18. Perspect Psychiatr Care. 2012. PMID: 22458722 Free PMC article. Clinical Trial.
References
-
- American Psychiatric Association (APA) Diagnostic and statistical manual of Mental Disorders. 4. Washington, DC: 2000.
-
- Kopelowicz A, Ventura J, Liberman PA, Mintz J. Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology. 2008;41(2):77–84. - PubMed
-
- Premkumar P, Cooke MA, Fannon D, Peters S, Michel TM, Aasen I, Murray RM, Kuipers E, Kumari V. Misattribution bias of threat related facial expression is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. Eur Psychiatry. 2008;23(1):14–19. - PMC - PubMed
-
- Fleischhacker WW, Cetkovick-Bakmas M, DeHert M, Hennekens CH, Lambert M, Leucht S, Maj M, McIntyre RS, Naber D, Newcomer JW, Olfson M, Osby U, Sartorius N, Lieberman JA. Comorbid somatic illnesses inpatients with severe mental disorders: Clinical, policy and research challenges. J Clin Psychiatry. 2008;69(4):514–519. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources